Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Transl Oncol ; 19(6): 711-717, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27909873

RESUMEN

PURPOSE: Many studies recently focus on complicated and expensive genomic tests, but the prognostic values of biochemical markers which are easily obtained in clinics are largely overlooked and without further exploration. This study assesses the association of neutrophil-lymphocyte-ratio (NLR) with prognosis of lung cancer patients. METHODS: In 1032 patients with histologically confirmed lung cancer, the association of pretreatment NLR values with overall survival (OS) was evaluated using a Cox proportional hazards model and the temporal relationship of longitudinal NLR was assessed using a mixed effects model. RESULTS: Compared to the patients with a low pretreatment NLR value, those with elevated NLR exhibited a statistically significant worse OS with a hazard ratio (HR) of 1.50 (P < 0.0001) after adjusting for age, gender, race, smoking status, drinking status, tumor stage, tumor grade, histology, and treatments. A significant trend of increasing HRs along with increasing NLR values was observed. The increased risk of death conferred by pretreatment NLR values reached a peak level around 2 years after diagnosis. Moreover, in longitudinal analysis, we observed a trend of dramatically increased NLR values in patients who died during follow-up, but stable NLR values in those who were still alive, with a significant interaction of death-alive status with follow-up time (P < 0.0001). CONCLUSIONS: Elevated NLR is a potential biomarker to identify lung cancer patients with poor prognosis and should be validated in a future clinical trial.


Asunto(s)
Neoplasias Pulmonares/sangre , Neoplasias Pulmonares/inmunología , Recuento de Linfocitos , Neutrófilos , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Supervivencia sin Enfermedad , Femenino , Humanos , Estimación de Kaplan-Meier , Neoplasias Pulmonares/mortalidad , Masculino , Persona de Mediana Edad , Pronóstico , Modelos de Riesgos Proporcionales
2.
Genet Mol Res ; 14(3): 9994-10000, 2015 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-26345935

RESUMEN

The aims of this study were to observe the differential expression of PI3K-AKT pathway-related genes in seizure-inducing brain lesions in type II focal cortical dysplasia, and to explore the relationship between gene expression and histological changes in dysplastic foci and their epileptogenic mechanism. Typical lesions in brain tissue from three patients with epilepsy induced by type II focal cortical dysplasia were selected for analysis, along with normal brain tissue from two control group individuals. Following quantitative expression analysis using the RT2 Profiler(TM) PI3K-AKT PCR Array, differential expression of the pathway related genes was detected in the focal brain tissue lesions, and gene function queries were performed. Compared with the control group, thirteen related genes appeared to exhibit marked differences in expression in epileptic lesions from patients with type II focal cortical dysplasia; those genes were found to be involved in regulation of cell size, morphology, adhesion, migration, and apoptosis, and in immunity, inflammation, and many other domains. The differential expression of multiple genes in the PI3K-AKT signaling pathway in type II focal cortical dysplasia may be an important molecular mechanism underlying histological changes and recurrent seizures.


Asunto(s)
Epilepsia/genética , Epilepsia/metabolismo , Expresión Génica , Malformaciones del Desarrollo Cortical de Grupo I/genética , Malformaciones del Desarrollo Cortical de Grupo I/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Transducción de Señal , Humanos
3.
Genet Mol Res ; 13(1): 323-35, 2014 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-24535859

RESUMEN

Reduced AMP-activated protein kinase (AMPK) expression has been shown to play a significant role in the cardiac dysfunction in heart failure. This study was designed to examine the effect of resveratrol, a potent activator of silent information regulator (SIRT1), on cardiac function and AMPK expression in heart failure. Adult male rat left anterior descending arteries were ligated, and they were fed with either a regular diet or a diet enriched with resveratrol. Heart failure was produced by myocardial infarction, and was associated with markedly increased AMPK and SIRT1 protein levels. Resveratrol treatment had a tremendous beneficial effect, both in terms of improving AMPK expression and on cardiac function. Decreased cardiac function and AMPK expression were also found in SIRT1 knockout (+/-) mice. In cultured cardiomyocytes, resveratrol increased AMPK and SIRT1 expressions, and overexpression of SIRT1 was found to be sufficient to activate AMPK in H9c2 cells. In contrast, pretreatment of cardiomyocytes with an SIRT1 antagonist, nicotinamide, blocked these beneficial effects of resveratrol. Therefore, the protective effects of resveratrol were found to be dependent on its ability to activate SIRT1 and improve AMPK expression. These results demonstrated that in heart failure, the enzymatic activity of cardiac SIRT1 is increased, which contributes to increased expression of AMPK, and resveratrol enhances the expression of AMPK and improves cardiac function through the activation of SIRT1.


Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Insuficiencia Cardíaca/tratamiento farmacológico , Sirtuina 1/metabolismo , Estilbenos/farmacología , Proteínas Quinasas Activadas por AMP/genética , Animales , Línea Celular , Células Cultivadas , Masculino , Ratones , Infarto del Miocardio/tratamiento farmacológico , Miocitos Cardíacos/efectos de los fármacos , Miocitos Cardíacos/metabolismo , Niacinamida/farmacología , Ratas , Resveratrol , Sirtuina 1/genética , Estilbenos/uso terapéutico , Regulación hacia Arriba , Función Ventricular/efectos de los fármacos
4.
Genet Mol Res ; 11(3): 2899-908, 2012 Aug 29.
Artículo en Inglés | MEDLINE | ID: mdl-22653645

RESUMEN

We explored a possible correlation of genetic instability and CpG methylation in the 5'-flanking region of the PAI-1 gene with clinicopathologic features of gastric cancer in Chinese patients and looked for molecular markers for diagnosing gastric tumor development. Microsatellite instability and loss of heterozygosity of the PAI-1 gene locus D7S515, D7S471 and pai-1 in 50 specimens of gastric cancer and relevant pericancerous tissues were detected by PCR-single strand conformation polymorphism (PCR-SSCP) with sliver staining. Methylation-specific PCR was used to detect CpG methylation in the 5'-flanking region of the PAI-1 gene. Microsatellite instability was significantly more common in the negative than in the positive serosa infiltration group of gastric cancer (42.86 vs 2.33%). The frequency of microsatellite instability was significantly lower in the cases with lymph node metastasis than in those without metastasis (18.18 vs 2.56%); however, it was significantly higher in the low differentiation group than that in the middle or high differentiation groups (21.05 vs 0.00%). CpG methylation in the 5'-flanking region of the PAI-1 gene did not differ significantly. Microsatellite instability and loss of heterozygosity of the PAI-1 gene apparently regulates the development of gastric cancer through different pathways. Microsatellite instability could be used as a molecular marker for the development of gastric cancer. CpG methylation in the 5'-flanking region of the PAI-1 gene appears not to be involved in the development of gastric cancer.


Asunto(s)
Región de Flanqueo 5'/genética , Pueblo Asiatico/genética , Islas de CpG/genética , Metilación de ADN/genética , Inestabilidad Genómica/genética , Inhibidor 1 de Activador Plasminogénico/genética , Neoplasias Gástricas/genética , Alelos , China , Sitios Genéticos/genética , Predisposición Genética a la Enfermedad , Humanos , Pérdida de Heterocigocidad/genética , Inestabilidad de Microsatélites , Reacción en Cadena de la Polimerasa , Neoplasias Gástricas/patología
5.
J Nat Prod ; 62(6): 824-8, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10395496

RESUMEN

Irlbacholine and a series of related analogues were synthesized and their antifungal activities against Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus were assessed. The natural bisphosphocholine, irlbacholine, was the most potent compound, its 22-carbon chain length appearing to be optimal.


Asunto(s)
Antifúngicos/aislamiento & purificación , Fosforilcolina/análogos & derivados , Plantas Medicinales/química , Antifúngicos/farmacología , Aspergillus fumigatus/efectos de los fármacos , Candida albicans/efectos de los fármacos , América Central , Cryptococcus neoformans/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Fosforilcolina/aislamiento & purificación , Fosforilcolina/farmacología , América del Sur
6.
Int J Epidemiol ; 24(1): 19-26, 1995 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-7797343

RESUMEN

BACKGROUND: Although the possible influence of oral contraceptives on risk of cervical carcinoma in situ has been the subject of multiple prior investigations, the results have been inconsistent. METHODS: Data from a multinational, collaborative case-control study were analysed to investigate further this possible relationship. To assess potential screening bias, some statistical analyses were restricted to subgroups of cases with and without symptoms at the time of their diagnosis. RESULTS: Relative risk estimates in relation to various features of oral contraceptive use tended to be highest for asymptomatic disease, lowest for disease presenting with vaginal bleeding, and intermediate for disease presenting with other symptoms, suggesting the presence of a screening bias. In women with vaginal bleeding, who are least likely to have been detected by routine screening, no elevated risk of cervical carcinoma in situ was observed in relation to ever having used combined oral contraceptives, but there was an increased risk in users of over 60 months' duration. An increasing trend in risk with duration of use was most pronounced in these women who first used oral contraceptives in the past 5-10 years; and in women who used oral contraceptives for more than 60 months, risk declined with time since last use. CONCLUSION: These findings could reflect a reversible effect of long-term use of oral contraceptives at an intermediate stage in the carcinogenic process, or a non-causal relationship due to unidentified sources of bias or confounding.


Asunto(s)
Carcinoma in Situ/inducido químicamente , Anticonceptivos Orales Combinados/efectos adversos , Neoplasias del Cuello Uterino/inducido químicamente , Adulto , Sesgo , Carcinoma in Situ/diagnóstico , Estudios de Casos y Controles , Chile , Factores de Confusión Epidemiológicos , Anticonceptivos Orales Combinados/administración & dosificación , Interpretación Estadística de Datos , Femenino , Humanos , México , Persona de Mediana Edad , Factores de Riesgo , Tailandia , Factores de Tiempo , Neoplasias del Cuello Uterino/diagnóstico
7.
Contraception ; 51(1): 25-31, 1995 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7750280

RESUMEN

The relationship of depot-medroxyprogesterone acetate (D-MPA) use to risk of cervical carcinoma in situ was investigated using data from a large multi-national, hospital-based case-control study. To avoid possible detection bias from Pap smear screening, final analyses were restricted to a subset of cases with symptoms at the time of their diagnosis of cervical carcinoma in situ. Relative to nonusers, the risk was elevated in women who had ever used DMPA and increased with duration of use. Decreasing trends in relative risk with times since first and last uses were observed in long-term users. Results from another portion of this same study did not show a relationship of invasive cervical cancer to DMPA use. These findings suggested that if DMPA increases the risk of cervical carcinoma in situ then either this is a reversible effect, or the cervical lesions induced by DMPA tend not to progress to invasive disease.


Asunto(s)
Carcinoma in Situ/inducido químicamente , Carcinoma in Situ/epidemiología , Acetato de Medroxiprogesterona/efectos adversos , Neoplasias del Cuello Uterino/inducido químicamente , Neoplasias del Cuello Uterino/epidemiología , Adulto , Estudios de Casos y Controles , Preparaciones de Acción Retardada , Femenino , Humanos , Acetato de Medroxiprogesterona/administración & dosificación , México/epidemiología , Persona de Mediana Edad , Factores de Riesgo , Tailandia/epidemiología , Organización Mundial de la Salud
8.
Adv Space Res ; 14(10): 701-5, 1994 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11540011

RESUMEN

This paper presents the observational results of space energetic particles obtained by the Cosmic Ray Composition Monitor (CRCM) onboard the Chinese satellite, Fengyun-1(B). These results, including those of a few solar proton events, the geomagnetically trapped particles and the anomalous cosmic ray components, were obtained from 3 September 1990 to 15 February 1991. The observed elements include H, He, C, N, O and Fe of energies from 4-23 MeV/u. It was found that the proton fluxes of the inner Radiation Belt (IRB) increased obviously during the period of solar proton event (SPE). A few kinds of heavy ions (Z > or = 6) were also detected in the IRB. As to the anomalous cosmic ray component (ACRC), in addition to C, N and O, anomalous iron particles were also recorded.


Asunto(s)
Radiación Cósmica , Protones , Monitoreo de Radiación/instrumentación , Actividad Solar , Nave Espacial/instrumentación , Océano Atlántico , Planeta Tierra , Elementos Químicos , América del Sur
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA